Stockreport

Jeito holds $1.2B close for biopharma fund as industry braces for next patent cliff [Yahoo! Finance]

JOHNSON MATTHEY S/ADR  (JMPLY) 
NASDAQ:AMEX Investor Relations: matthey.com/investor
PDF Pharma's $180 billion patent cliff will create more attractive opportunities in the space. Jeito II beat its target and is almost double the size of its predecessor, w [Read more]